Indomethacin therapy in hydramnios.
J Postgrad Med
;
2000 Jul-Sep; 46(3): 176-8
Artigo
em Inglês
| IMSEAR
| ID: sea-115270
ABSTRACT
AIM:
The use of indomethacin in treatment of hydramnios was evaluated. SUBJECTS &METHODS:
Twelve patients with symptomatic hydramnios were treated with indomethacin (2.2- 3.0 mg/kg body weight/day).RESULTS:
The treatment was started at a gestational age of 31.17-/+7.94 weeks and continued for 3.74-/+2.3 weeks. Eleven patients responded to the therapy both subjectively and objectively and pregnancies were prolonged by 4.6-/+3.1 weeks (range 0.1-10 weeks). Five women had term deliveries. Six patients had a favourable perinatal outcome. Four patients who had a known congenital anomaly in the foetus, delivered stillborn babies or had an early neonatal death. One patient who did not follow up after commencing therapy delivered a full-term stillbirth. One patient delivered within 1 day of starting therapy. Indomethacin therapy caused no maternal complications.CONCLUSION:
Indomethacin was effective in the management of hydramnios and preventing it's complications.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Índice de Gravidade de Doença
/
Feminino
/
Humanos
/
Gravidez
/
Esquema de Medicação
/
Resultado da Gravidez
/
Anti-Inflamatórios não Esteroides
/
Indometacina
/
Seguimentos
/
Ultrassonografia Pré-Natal
Tipo de estudo:
Estudo diagnóstico
/
Estudo observacional
/
Estudo prognóstico
Idioma:
Inglês
Revista:
J Postgrad Med
Ano de publicação:
2000
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS